Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells

Sara Rubio, Francisco Estévez, Javier Cabrera, Russel J. Reiter, Juan Loro, José Quintana

Research output: Contribution to journalArticlepeer-review

70 Scopus citations

Abstract

Melatonin is an indoleamine that is synthesized in the pineal gland and has an extensive repertoire of biological activities. In the present study, we found that melatonin reduced the growth of the human myeloid leukemia cells HL-60, inhibiting progression from G1 to S phase of the cell cycle and increasing apoptotic cell death. Furthermore, melatonin treatment elevated cytochrome c release from mitochondria and augmented caspase-3 and caspase-9 activities. Upregulation of Bax and downregulation of Bcl-2 was also observed upon melatonin treatment. The effects of melatonin were found not to be mediated by membrane receptors for the indoleamine. Together, our results suggest that melatonin reduces the viability of HL-60 cells via induction of apoptosis primarily through regulation of Bax/Bcl-2 expression.

Original languageEnglish (US)
Pages (from-to)131-138
Number of pages8
JournalJournal of pineal research
Volume42
Issue number2
DOIs
StatePublished - Mar 1 2007

Keywords

  • Apoptosis
  • Cell cycle
  • Cell proliferation
  • HL-60 cells
  • Melatonin

ASJC Scopus subject areas

  • Endocrinology

Fingerprint Dive into the research topics of 'Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells'. Together they form a unique fingerprint.

Cite this